Benjamin Besse

52PUBLICATIONS
624CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCellular immunologyComputational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (52)

|Jul 15, 2026
Intratumoral Immune Heterogeneity Drives Divergent Outcomes to PD-(L)1 Blockade in Lung Cancer.

|Jul 13, 2026
Role of ctDNA Tumor Fraction in Selecting Immunotherapy Based Regimens in Advanced Non-small Cell Lung Cancer.

|Jun 22, 2026
Targeting KRAS codon 13 mutations using direct combination approaches in non-small cell lung cancer.

|Jun 01, 2026
Selpercatinib in Early-Stage RET Fusion-Positive Non-Small-Cell Lung Cancer.

|May 08, 2026
Characterization and clinical management of adverse events following treatment with repotrectinib: a TRIDENT-1 analysis.

|Apr 07, 2026
Retreatment with First-Generation Selective RET Inhibitors in RET-Rearranged NSCLC Pretreated with Selpercatinib or Pralsetinib: Results from the RET-MAP Registry.

Arianna Marinello, Julia K Rotow, Meghanne Lomibao

Pageof 9

Frequent Collaborators

12 joint publications

Ludovic Lacroix

10 joint publications

Luc Friboulet

10 joint publications

Yohann Loriot

10 joint publications

Mihaela Aldea